Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A ca judge that is federal to nix direct purchasers’ claims alleging the pharmaceutical organizations involved with anti-competitive conduct to block generic competition and keep HIV medicine costs artificially high, arguing the matches ought to be delivered to arbitration […]